{
  "e4553b95-b2f9-46c4-a096-4fff493b0ff2": {
    "pk": "e4553b95-b2f9-46c4-a096-4fff493b0ff2",
    "project_name": null,
    "name": "Salma Hassan",
    "bio": "As a researcher dedicated to improving cancer diagnostics, my work primarily focuses on the early detection and subtype classification of non-small cell lung cancer (NSCLC), a leading cause of cancer-related deaths globally. I am passionate about integrating multi-modal data to enhance diagnostic precision. In my recent research, I developed an innovative methodology that fuses medical imaging\u2014specifically CT and PET scans\u2014with clinical health records and genomic data. By leveraging advanced machine learning models like MedClip and BEiT for sophisticated image feature extraction, I have set a new standard in computational oncology.\n\nMy findings demonstrate significant advancements in NSCLC detection and classification, achieving an impressive accuracy of 94.04% with our leading multi-modal classifier model. This work not only surpasses existing approaches but also highlights the potential for transforming NSCLC diagnostics, enabling earlier detection and more effective treatment planning. I am committed to advancing the field of oncology through innovative research that ultimately leads to improved patient outcomes in lung cancer care.",
    "collaborators": [
      "Hamad Al Hammadi",
      "Ibrahim Mohammed",
      "Muhammad Haris Khan"
    ],
    "domain": [
      "Medical Imaging",
      "Machine Learning",
      "Oncology",
      "Multi-modal Data"
    ],
    "institute": null,
    "embed": null,
    "is_leader_candidate": true,
    "is_member_candidate": true,
    "is_reviewer_candidate": true,
    "is_chair_candidate": true
  },
  "3ed27973-417c-4e9e-b1a1-3d4ca6023c08": {
    "pk": "3ed27973-417c-4e9e-b1a1-3d4ca6023c08",
    "project_name": null,
    "name": "Hamad Al Hammadi",
    "bio": "As a researcher dedicated to the early detection and classification of non-small cell lung cancer (NSCLC), I am passionate about leveraging multi-modal data to enhance diagnostic precision. My recent work focuses on integrating advanced medical imaging techniques, such as CT and PET scans, with clinical health records and genomic data. By employing sophisticated machine learning models like MedClip and BEiT, I have developed a novel fusion methodology that significantly improves the accuracy of NSCLC detection and subtype classification.\n\nIn my latest study, I achieved an impressive accuracy of 94.04% with our leading multi-modal classifier, demonstrating substantial enhancements in key performance metrics such as precision, recall, and F1-score. I believe that this innovative approach not only sets a new standard in computational oncology but also has the potential to transform lung cancer diagnostics. My goal is to facilitate earlier detection and more effective treatment planning, ultimately leading to better patient outcomes in lung cancer care. I am excited about the future of this research and its implications for improving healthcare delivery in oncology.",
    "collaborators": [
      "Salma Hassan",
      "Ibrahim Mohammed",
      "Muhammad Haris Khan"
    ],
    "domain": [
      "Medical Imaging",
      "Machine Learning",
      "Oncology",
      "Multi-modal Data"
    ],
    "institute": null,
    "embed": null,
    "is_leader_candidate": true,
    "is_member_candidate": true,
    "is_reviewer_candidate": true,
    "is_chair_candidate": true
  },
  "d9a4f800-90db-4cb6-b65c-b68a781247fb": {
    "pk": "d9a4f800-90db-4cb6-b65c-b68a781247fb",
    "project_name": null,
    "name": "Ibrahim Mohammed",
    "bio": "I am a researcher dedicated to addressing the challenges posed by the SARS-CoV-2 pandemic through innovative therapeutic approaches. My recent work focuses on the identification of natural compounds that can inhibit the human transmembrane protease serine type 2 (TMPRSS2), a critical enzyme that facilitates viral entry into host cells. By employing advanced in-silico methods, I constructed a 3D model of TMPRSS2 and screened 95 natural compounds derived from microalgae. This effort led to the identification of 17 promising candidates with binding affinities comparable to the standard inhibitor, camostat.\n\nMy research emphasizes the importance of understanding the pharmacokinetic and pharmacodynamic profiles of these compounds, as well as their potential toxicity. The top candidates, including apigenin, catechin, and epicatechin, demonstrated strong binding energies, highlighting their potential as therapeutic agents against SARS-CoV-2. I believe that further in vivo and in vitro studies are essential to translate these findings into viable drug candidates. My work aims to contribute to the global effort in combating COVID-19 by exploring the untapped potential of natural compounds in drug development.",
    "collaborators": [],
    "domain": [
      "Drug Discovery",
      "Computational Biology",
      "SARS-CoV-2",
      "Natural Products"
    ],
    "institute": null,
    "embed": null,
    "is_leader_candidate": true,
    "is_member_candidate": true,
    "is_reviewer_candidate": true,
    "is_chair_candidate": true
  },
  "9e067d47-3014-49ff-bbca-bae91992ecf1": {
    "pk": "9e067d47-3014-49ff-bbca-bae91992ecf1",
    "project_name": null,
    "name": "Muhammad Haris Khan",
    "bio": "I am a researcher dedicated to advancing the field of multimodal systems, particularly in the intersection of audio-visual technologies and computer vision. My recent work has focused on the intricate relationship between faces and voices, culminating in the Face-voice Association in Multilingual Environments (FAME) Challenge 2024, which explores this association in multilingual contexts. I am passionate about improving animal welfare through technology, having developed a large-scale annotated dataset of animal faces to facilitate better understanding and monitoring of animal behavior.\n\nMy research also delves into enhancing object detection and segmentation methods, particularly in challenging scenarios such as domain generalization and personalized instance segmentation. I have proposed innovative frameworks like PerSense for one-shot personalized instance segmentation and developed techniques for calibrating deep neural networks, especially in safety-critical applications. My work emphasizes the importance of model calibration, addressing the overconfidence of deep learning models, and ensuring their reliability in real-world applications.\n\nI strive to create robust, efficient, and scalable solutions that leverage the latest advancements in deep learning and multimodal integration. My contributions aim to push the boundaries of what is possible in computer vision, making significant strides in both theoretical understanding and practical applications. I am committed to sharing my findings and tools with the research community to foster collaboration and innovation.",
    "collaborators": [
      "Muhammad Akhtar Munir",
      "Mohsen Ali",
      "Muhammad Saad Saeed",
      "Shah Nawaz",
      "Muhammad Haroon Yousaf",
      "Fahad Shahbaz Khan",
      "M. Saquib Sarfraz",
      "Salman Khan",
      "Muhammad Zaigham Zaheer",
      "Markus Schedl"
    ],
    "domain": [
      "Multimodal Learning",
      "Computer Vision",
      "Deep Learning",
      "Object Detection"
    ],
    "institute": null,
    "embed": null,
    "is_leader_candidate": true,
    "is_member_candidate": true,
    "is_reviewer_candidate": true,
    "is_chair_candidate": true
  }
}
